Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. China Health Industries Holdings's current 3-Month Share Buyback Ratio was 0.00%.
China Health Industries Holdings (OTCPK:CHHE) 3-Month Share Buyback Ratio Explanation
A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
China Health Industries Holdings 3-Month Share Buyback Ratio Related Terms
CHHE vs BIOE, CRYM, TXMD: 3-Month Share Buyback Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, China Health Industries Holdings's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Industries Holdings 3-Month Share Buyback Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Health Industries Holdings's 3-Month Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where China Health Industries Holdings's 3-Month Share Buyback Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 3-Month Share Buyback Ratio of 0.00 mean?
China Health Industries Holdings (CHHE) has a 3-Month Share Buyback Ratio of 0.00 as of Mar. 2024. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for China Health Industries Holdings and its competitors.
Is China Health Industries Holdings' 3-Month Share Buyback Ratio too high?
China Health Industries Holdings' current 3-Month Share Buyback Ratio is 0.00. Overall, China Health Industries Holdings has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does China Health Industries Holdings' 3-Month Share Buyback Ratio compare to BIOE and CRYM?
China Health Industries Holdings' 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Drug Manufacturers company?
A good 3-Month Share Buyback Ratio depends on the Drug Manufacturers industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for China Health Industries Holdings and its competitors. China Health Industries Holdings's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Industries Holdings stock overvalued right now?
China Health Industries Holdings (CHHE) has a current 3-Month Share Buyback Ratio of 0.00. The current 3-Month Share Buyback Ratio is 0.00. China Health Industries Holdings' overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For China Health Industries Holdings (CHHE), the current 3-Month Share Buyback Ratio is 0.00 as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
China Health Industries Holdings Inc. is a China-based company engaged in the production, marketing, and distribution of health-related products. Through its subsidiaries, it develops and sells medicines, health supplements, medical devices, and cosmetics, with product lines that have included hemp-based foods and medicines, externally applied medicines, and health foods. The company operates through reportable segments including Humankind, HLJ Huimeijia, and Others, with the Humankind segment historically generating the largest share of revenue. Its customers are primarily consumers and distributors within the Chinese market, and revenue is derived mainly from the sale of finished health and pharmaceutical products rather than services. The business is headquartered in Heilongjiang Province, China, and its shares trade on U.S. over-the-counter markets.
20GF Score
Get the complete analysis for CHHE
3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHHE has been successfully added to your 
